| |
 |
|
Class Information
Number: 514/568
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Radical -xh acid, or anhydride, acid halide or salt thereof (x is chalcogen) doai > Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) > Benzene ring nonionically bonded
Description: Subject matter wherein the active ingredient contains a benzene ring, nonionically bonded thereto.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5401510 |
Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation |
Mar. 28, 1995 |
| 5393768 |
Leukotriene antagonists |
Feb. 28, 1995 |
| 5391575 |
Method for treating neurofibromatosis |
Feb. 21, 1995 |
| 5387605 |
Carboxylic acids that are effective against TB |
Feb. 7, 1995 |
| 5385942 |
Quinone derivatives and pharmacological use |
Jan. 31, 1995 |
| 5378728 |
Benzoic acid derivatives as antidiabetic agents |
Jan. 3, 1995 |
| 5360611 |
Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation |
Nov. 1, 1994 |
| 5360815 |
Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis |
Nov. 1, 1994 |
| 5360820 |
Medical use for tachykinin antagonists |
Nov. 1, 1994 |
| 5352701 |
Leukotriene-B.sub.4 antagonist compounds and their use as pharmaceutical agents |
Oct. 4, 1994 |
| 5342835 |
Antifungal agents based on amides containing a phenyl group |
Aug. 30, 1994 |
| 5336507 |
Use of charged phospholipids to reduce nanoparticle aggregation |
Aug. 9, 1994 |
| 5336271 |
Method for increasing the proportion of a crystalline organic compound which remains uncrystallized in a composite particulate product and suppressing recrystallization |
Aug. 9, 1994 |
| 5328909 |
Cyclopropenone derivatives |
Jul. 12, 1994 |
| 5318770 |
Trifluoromethyl analogs of X-ray contrast media for magnetic resonance imaging |
Jun. 7, 1994 |
| 5314909 |
Use of non-steroidal antiiflammatory agents in macular degeneration |
May. 24, 1994 |
| 5292771 |
Substituted .beta.-diketones and their use |
Mar. 8, 1994 |
| 5286751 |
Sustained/enhanced antipyretic response |
Feb. 15, 1994 |
| 5274002 |
Trisubstituted phenyl analogs having activity for congestive heart failure |
Dec. 28, 1993 |
| 5271939 |
Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation |
Dec. 21, 1993 |
| 5246966 |
Substituted alkenoic acid and its derivatives |
Sep. 21, 1993 |
| 5244922 |
Methods for treating viral infections |
Sep. 14, 1993 |
| 5215977 |
Method for treating leg weakness in fowl |
Jun. 1, 1993 |
| 5211947 |
Method for lowering blood cholesterol levels with granulocyte-macrophage colony stimulating factor |
May. 18, 1993 |
| 5202355 |
Method of inhibiting aldose reductase in diabetic hosts using phenol derivatives |
Apr. 13, 1993 |
| 5190981 |
Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease |
Mar. 2, 1993 |
| 5179097 |
Salts of non-steroidal anti-inflammatory carboxylic acids and anti-lipidemic carboxylic acids |
Jan. 12, 1993 |
| 5166171 |
6-phenoxymethyl-4-hydroxytetrahydropyran-2-ones and 6-thiphenoxymethyl-4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters, and in |
Nov. 24, 1992 |
| 5153227 |
Phenylsulfonyl nitromethanes as aldose reductase inhibitors |
Oct. 6, 1992 |
| 5147892 |
Benzyl ketones and fungicides containing them |
Sep. 15, 1992 |
| 5141959 |
Isoprenoid phospholipase A2 inhibitors and preparations comprising same |
Aug. 25, 1992 |
| 5134165 |
Method of treatment for loss of vision due to ophthalmic surgery |
Jul. 28, 1992 |
| 5118710 |
Sulfur-containing acrylic esters and fungicides containing them |
Jun. 2, 1992 |
| 5112864 |
PLA.sub.2 inhibitors as antiinflammatories |
May. 12, 1992 |
| 5106407 |
Iodones and methods for antimicrobial use |
Apr. 21, 1992 |
| 5091180 |
Protection against rhabdomyolysis-induced nephrotoxicity |
Feb. 25, 1992 |
| 5089405 |
Process for the preparation of optically active 2-arylpropionic acids and pharmaceutical compositions containing the same |
Feb. 18, 1992 |
| 5086067 |
LTB.sub.4 synthesis inhibitors |
Feb. 4, 1992 |
| 5068252 |
Methods of using phenylethenyl compounds having retinoid-like activity |
Nov. 26, 1991 |
| 5066480 |
Method of preventing or reducing adverse reactions to protamine using a thromboxane A.sub.2 receptor antagonist |
Nov. 19, 1991 |
| 5064860 |
Method of inhibiting superoxide generation |
Nov. 12, 1991 |
| 5034416 |
Carboxylic acid compositions |
Jul. 23, 1991 |
| 5032572 |
Polymers containing cross-linked azo bonds, which polymers are useful for releasing therapeutic agents into the lower gastrointestinal tract |
Jul. 16, 1991 |
| 5025019 |
Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
Jun. 18, 1991 |
| 5025036 |
Catechol carboxylic acids |
Jun. 18, 1991 |
| 5013757 |
Physiologically active substance Tan-931, its derivatives, their production and use |
May. 7, 1991 |
| 5013756 |
Catechol derivatives, a process of preparation thereof, and therapeutical compositions containing the same |
May. 7, 1991 |
| 5006556 |
Dichloroaniline derivatives for the therapy or prophylaxysis of a disease associated with reversible airway obstruction |
Apr. 9, 1991 |
| 5006340 |
Curable compositions for dental drugs having sustained release property |
Apr. 9, 1991 |
| 4996232 |
Reducing bacterial content in water |
Feb. 26, 1991 |
|
|
|
